QLC5513 Alone or in Combination With QL1706 in Previously Treated Advanced or Metastatic TNBC.

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2026
The study will evaluate the safety and efficacy of QLC5513 alone or in combination with QL1706 in patients with advanced or metastatic triple-negative breast cancer (TNBC) who had received ≥1 line of prior systematic therapy.
Epistemonikos ID: f085b542d19be0a730e7819917f2b2afd0f76773
First added on: Apr 04, 2026